![]() |
Name |
2-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid
|
Molecular Formula | C16H22O4 | |
IUPAC Name* |
2-(2-ethylhexoxycarbonyl)benzoic acid
|
|
SMILES |
CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)O
|
|
InChI |
InChI=1S/C16H22O4/c1-3-5-8-12(4-2)11-20-16(19)14-10-7-6-9-13(14)15(17)18/h6-7,9-10,12H,3-5,8,11H2,1-2H3,(H,17,18)
|
|
InChIKey |
DJDSLBVSSOQSLW-UHFFFAOYSA-N
|
|
Synonyms |
4376-20-9; 2-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid; Mehp; Mono(2-ethylhexyl) phthalate; PHTHALIC ACID MONO-2-ETHYLHEXYL ESTER; 2-Ethylhexyl hydrogen phthalate; Mono(2-ethylhexyl)phthalate; Monoethylhexyl phthalate; MONO-2-ETHYLHEXYL PHTHALATE; Mono-(2-ethylhexyl)phthalate; 2-(2-ethylhexoxycarbonyl)benzoic acid; (2-Ethylhexyl) hydrogen phthalate; rac Mono(ethylhexyl) Phthalate; 1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester; mono(ethylhexyl) phthalate; phthalic acid, 2-ethylhexyl ester; 2-{[(2-ethylhexyl)oxy]carbonyl}benzoic acid; FU2EWB60RT; rac Mono(ethylhexyl) Phthalate-d4; Monoethylhexyl phthalic acid; Phthalic acid, mono-2-ethylhexyl ester; Phthalic acid, mono-(2-ethylhexyl) ester; 1276197-22-8; CHEBI:17243; PHTHALIC ACID MONOOCTYL ESTER; Phthalic acid mono-2-ethylhexylester; NCGC00090773-04; Phthalic acid, mono-2-ethylhexyl ester 100 microg/mL in Acetonitrile; BAR 1; Phthalate, mono(2-ethylhexyl); CCRIS 1742; 2-([(2-Ethylhexyl)oxy]carbonyl)benzoic acid; EINECS 224-477-1; UNII-FU2EWB60RT; mono-ethylhexyl; Mono-(2-ethylhexyl) phthalate; monoethylhexylphthalate; mono-ethylhexylphthalate; 2-(((2-Ethylhexyl)oxy)carbonyl)benzoicacid; DSSTox_CID_5680; DSSTox_RID_77879; DSSTox_GSID_25680; phthalicacidmonoethylhexylester; phthalicacid,2-ethylhexylester; SCHEMBL472689; mono-(2-ethyl)hexyl phthalate; 1,2-Benzenedicarboxylic Acid Mono(2-ethylhexyl) Ester; PHTHALICACIDMONOETHYLHEXYL; CHEMBL1867438; DTXSID2025680; Monoethylhexyl phthalate (mEHP); Mono-(2-ethylhexyl) phthalate-d4; ACT03365; Tox21_400076; MFCD00041500; AKOS015902975; CS-W019178; HY-W018392; 2-(2-ethylhexyloxycarbonyl)benzoic acid; PHTHALICACIDMONO-2-ETHYLEXYLESTER; NCGC00090773-01; NCGC00090773-02; NCGC00090773-03; NCGC00090773-05; NCGC00090773-06; DS-16446; CAS-4376-20-9; DB-007821; 2-[(2S)-2-ethylhexoxy]carbonylbenzoic acid; FT-0600523; Phthalic acid mono-2-ethylhexyl ester liquid; Phthalic acid mono-2-ethylhexyl ester, 97%; C03343; Phthalic acid hydrogen 1-(2-ethylhexyl) ester; 2-([(2-Ethylhexyl)oxy]carbonyl)benzoic acid #; PHTHALIC ACID, MONO(2-ETHYLHEXYL) ESTER; A826416; Phthalic acid 1-hydrogen 2-(2-ethylhexyl) ester; phthalic acid mono-2-ethylhexyl ester, AldrichCPR; 1,2-benzenedicarboxylicacid,mono(2-ethylhexyl)ester; 2-((2-(ETHYL)HEXYLOXY)CARBONYL)BENZOIC ACID; BRD-A18246003-001-01-1; Q26841225; 1,2-BENZENEDICARBOXYLIC ACID, 1-(2-ETHYLHEXYL) ESTER
|
|
CAS | 4376-20-9 | |
PubChem CID | 20393 | |
ChEMBL ID | CHEMBL1867438 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 278.34 | ALogp: | 4.0 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 63.6 | Aromatic Rings: | 1 |
Heavy Atoms: | 20 | QED Weighted: | 0.714 |
Caco-2 Permeability: | -4.632 | MDCK Permeability: | 0.00002450 |
Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.013 |
30% Bioavailability (F30%): | 0.145 |
Blood-Brain-Barrier Penetration (BBB): | 0.211 | Plasma Protein Binding (PPB): | 96.19% |
Volume Distribution (VD): | 0.22 | Fu: | 2.02% |
CYP1A2-inhibitor: | 0.358 | CYP1A2-substrate: | 0.435 |
CYP2C19-inhibitor: | 0.083 | CYP2C19-substrate: | 0.074 |
CYP2C9-inhibitor: | 0.596 | CYP2C9-substrate: | 0.128 |
CYP2D6-inhibitor: | 0.295 | CYP2D6-substrate: | 0.099 |
CYP3A4-inhibitor: | 0.083 | CYP3A4-substrate: | 0.076 |
Clearance (CL): | 2.689 | Half-life (T1/2): | 0.72 |
hERG Blockers: | 0.287 | Human Hepatotoxicity (H-HT): | 0.27 |
Drug-inuced Liver Injury (DILI): | 0.652 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.006 | Maximum Recommended Daily Dose: | 0.014 |
Skin Sensitization: | 0.174 | Carcinogencity: | 0.172 |
Eye Corrosion: | 0.031 | Eye Irritation: | 0.983 |
Respiratory Toxicity: | 0.539 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000157 | ![]() |
0.694 | D0GY5Z | ![]() |
0.406 | ||
ENC000301 | ![]() |
0.678 | D0Y0JH | ![]() |
0.350 | ||
ENC002794 | ![]() |
0.613 | D07HBX | ![]() |
0.344 | ||
ENC000290 | ![]() |
0.602 | D0N3UL | ![]() |
0.333 | ||
ENC001802 | ![]() |
0.571 | D0A5CM | ![]() |
0.313 | ||
ENC000586 | ![]() |
0.571 | D0X4FM | ![]() |
0.313 | ||
ENC000090 | ![]() |
0.542 | D08HQK | ![]() |
0.301 | ||
ENC000300 | ![]() |
0.522 | D0P5GE | ![]() |
0.299 | ||
ENC001801 | ![]() |
0.506 | D0E9WO | ![]() |
0.298 | ||
ENC000154 | ![]() |
0.500 | D05OFX | ![]() |
0.296 |